EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
Press releases
June 3, 2024
BIOPHTA 6.5 million Euros Seed Funding
Paris, June 3, 2024
BIOPHTA, a preclinical biotech company developing a game-changing technology for the treatment of eye diseases, has just closed a € 6.5 million Seed round to bring its patented technology to clinical development.
This funding round was led by leading European VCs – UI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity Partners), Elaia and GO Capital – as well as one major ophthalmology player, Unither Pharmaceuticals and HTL Biotechnology, the global leader in production and development of pharma grade biopolymers.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles April 13, 2026EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
-
Articles March 19, 2026HTL Biotechnology at PCHi 2026 in Hangzhou
HTL Biotechnology recently took part in PCHi (Personal Care and Homecare Ingredients), one of the leading events for the personal care industry, held in Hangzhou, China.
-
Articles February 16, 2026Lunar New Year 2026: Entering the Year of the Fire Horse
From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.